相关实验视频
Updated: Jun 18, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
829
抑制RHOA活动可以保持长期冷藏血小板的生存和静血功能
Shailaja Hegde1,2, Huzoor Akbar3, Ashley M Wellendorf2
1Hoxworth Blood Center, University of Cincinnati College of Medicine, Cincinnati, OH.
Blood
|August 1, 2024
概括
血小板冷会造成损伤,但抑制RHOA (RAS同类家族,A成员) 可以防止这些病变. 这一突破提高了血小板输血的安全性和有效性,用于患有血小板缺血的患者.
科学领域:
- 血液学 血液学 血液学
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 血小板输血对于治疗血栓缺血患者的出血至关重要.
- 当前的室温储存存在细菌污染的风险,而冷藏会导致分子损伤和快速清除.
- 了解冷藏病变对于改善血小板输血治疗至关重要.
研究的目的:
- 为了阐明冷藏诱导的血小板损伤背后的分子机制.
- 确定治疗点,以预防感冒引起的血小板损伤.
- 评估新型抑制剂在冷藏期间保护血小板功能的有效性.
主要方法:
- 在小鼠模型中进行信号通路分析,基因操纵和药理学抑制.
- 对血小板膜微域,脂质和蛋白质分布 (GPIbα) 的评估.
- 评估代谢流量,线粒体呼吸和体内静血功能.
主要成果:
- 冷感激活RHOA (RAS同类家族,A成员) GTPase驱动主要的冷藏病变.
- 抑制RHOA可以防止损伤,保护血小板结构,脂质完整性和GPIbα分布.
- 抑制RHOA可以维持血小板代谢和线粒体呼吸.
- 用RHOA抑制剂治疗的冷储人体血小板显示在体内血液循环和静血功能得到改善.
结论:
- RHOA激活是冷藏引起的血小板损伤的关键驱动因素.
- 药理上抑制RHOA提供了一个有希望的策略,以防止冷藏病变.
- 这种方法提高了血小板输血的安全性和有效性,用于血小板缺血患者.
相关概念视频
Formation of the Platelet Plug
5.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
659
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
659
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
505
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
505
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
Introduction to Hemostasis
6.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
6.9K

